FN Media Group Presents Microsmallcap.com Market Commentary
New York, NY – March 23, 2022 – The Metaverse could soon have its own pharmacy after CVS revealed its plans to sell virtual goods and provide healthcare services in the virtual world. As CNBC reported on March 4, the pharmacy giant filed a trademark with the U.S. Patent Trade Office for its logo and plans to open an online store. CVS will offer downloadable virtual products including “prescription drugs, health, wellness, beauty and personal care products.” The company also wants to bring some of the health services it offers in stores to a virtual setting, such as “non-emergency medical treatments services, wellness programs, advisory services related to nutrition, health lifestyle and nutrition services… and counseling.” Meanwhile, telehealth companies Mednow Inc. (TSXV:MNOW) (OTCQB:MDNWF), Teladoc Health (NYSE:TDOC), Goodrx Holdings Inc (NASDAQ: GDRX), Medtronic plc (NYSE:MDT), and American Well Corp (NYSE:AMWL) are creating digital products and services with an aim to disrupt the $1 trillion global pharmacy market.
Canada’s on-demand virtual pharmacy Mednow Inc. (TSXV:MNOW) (OTCQB:MDNWF) provides healthcare technology that offers virtual access with exceptional care.
Mednow continues to expand within Canada, with operations in British Columbia, Ontario and Nova Scotia as well as final approval for a new flagship fulfillment center in Toronto. The company plans to launch its Manitoba and Quebec fulfillment centres in April 2022 and its Alberta fulfillment center summer 2022.
On March 7, Mednow announced it has entered a deal to acquire Mednow East, an online pharmacy delivering prescriptions in the Province of Ontario. Based in Toronto, Mednow East uses the Mednow marketing and technology platform for lead generation, prescription fulfillment and customer service pursuant to the Pharmacy Agreement. This acquisition may help Mednow in its mission to build a national pharmacy footprint.
Mednow had a strong first quarter with a 50% increase in patient numbers to 20,000 patients. The company also reported revenue growth of 375% or C$570,000 compared to a fourth quarter revenue of C$120,000.
For more information on Mednow Inc. (TSXV:MNOW) (OTCQB:MDNWF), please visit this link.
Telehealth Companies Launch New Digital Tools
Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, and Amazon have teamed up to launch Teladoc on Alexa. The launch of voice-activated general medical virtual care on supported Echo devices, such as an Echo, an Echo Dot, and an Echo Show with Amazon Alexa is a first-of-its-kind experience. Customers in the United States are now be able to connect with a Teladoc care provider 24/7 from supported Echo devices for general medical needs. Teladoc on Alexa will initially launch via audio with video tours coming soon.
Goodrx Holdings Inc (NASDAQ: GDRX) a consumer-focused digital healthcare platform, has entered into a definitive agreement to acquire vitaCare Prescription Services from TherapeuticsMD for $150 million in cash, with additional consideration of $7 million based on vitaCare’s financial performance through 2023.VitaCare is a technology platform that helps patients overcome obstacles to accessing and adhering to brand name medications. This acquisition may allow GoodRx to help more patients receive their prescriptions in an efficient, affordable and transparent way, and to follow their prescribed treatments for as long as necessary.
On March 9, Medtronic plc (NYSE:MDT) a global healthcare technology leader, announced it has signed a contract with Vizient, a leading U.S. healthcare performance improvement company, to add Touch Surgery Enterprise to Vizient’s offerings. Vizient serves more than half of the nation’s healthcare providers including academic medical centers, community hospitals, pediatric facilities and non-acute care providers. Touch Surgery is the first AI-powered video management and analytics platform for the OR. It gives surgical teams easy access to video and procedural information.
Telehealth leader American Well Corp (NYSE:AMWL) and global innovator LG Electronics have joined forces to partner on digital health innovations. With a common goal of improving patient care, this technology collaboration will focus on developing new digital healthcare services and solutions, starting with hospital care in the United States, where LG is the leading provider of smart TVs for patient rooms. LG will develop a healthcare platform to host Amwell‘s digital healthcare platform services, leveraging LG devices and peripheral technologies.
Amwell‘s SilverCloud Health has launched a new six course program suite to address a wide range of family mental health issues. The suite offers programs, content, interactive tools and videos aimed at addressing family mental health, in direct response to the needs of the COVID-19 pandemic and recent world events. The programs are delivered digitally, which also helps improve access to care for those in need.
Mednow Inc. (TSXV:MNOW) (OTCQB:MDNWF) has grown its product offerings since its March 2021 initial public offering (IPO), primarily through its acquisition of strategic pharmacy and healthcare businesses. The company wants to be an industry leader as the world embraces digital pharmacy. Mednow aims to accelerate growth by expanding its brand within Canada through the planned launch of fulfillment centers in Quebec, Manitoba, and Alberta this year.
PAID ADVERTISEMENT. This communication is a paid advertisement for Mednow Inc. (“Mednow” or the “Company”) to enhance public awareness of the Company, its products, its industry and as a potential investment opportunity. NativeAds, Inc. (“NativeAds”) and its owners, managers, employees, and assigns were paid by the Company to create, produce and distribute this advertisement, as previously disclosed in the news release of the Company dated March 12, 2021. This compensation should be viewed as a major conflict with NativeAds’ ability to be unbiased.
This communication is not intended as, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Company purport to provide a complete analysis of the Company or its financial position. The Company is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the Company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the profiled company’s SEDAR and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk.
This communication is based on information generally available to the public and on and does not contain any material, non-public information.
FORWARD-LOOKING STATEMENTS. This communication includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the timing of operations beginning in Manitoba, Saskatchewan and Nova Scotia, receipt of all required regulatory approvals from the Manitoba College of Pharmacists, the Nova Scotia College of Pharmacists and other regulatory bodies with oversight of pharmacy practices, the ability to service clients in Saskatchewan and Manitoba from the Manitoba fulfillment centre, the ability to service clients in Nova Scotia from the Nova Scotia fulfillment centre and the benefits of a national presence. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends,” “anticipates,” “it is expected,” or variations of such words and phrases, or statements that certain actions, events or results “may,” “could,” “should,” or “would” occur. Forward-looking statements are based on certain material assumptions and analyses made by management of the Company and the opinions and estimates of management of the Company as of the date of this communication, including that the transactions contemplated herein will close on the terms and timeline as anticipated by the management of the Company and that the Company will receive all required regulatory approvals. Although the Company considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the transactions contemplated herein will not close on the terms and timeline as anticipated by the management of the Company, or at all, the risk that the Company will not receive required regulatory approvals and the other risks and uncertainties applicable to the Company and the business of the Company as set forth in the Company’s final long form prospectus dated February 26, 2021 and its other disclosure available under the Company’s profile at www.sedar.com. There can be no assurance that the transactions contemplated in this communication will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations. We seek safe harbor.
RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
Disclaimer: Microsmallcap.com (MSC) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Mednow Inc. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
FN Media Group, LLC
The post Pharmacy Giant Files Patent to Join the Metaverse appeared first on Financial News Media.